Vanderbilt research is blazing a trail for the application of game theory to genomic and health data reidentification risk.

Vanderbilt-Ingram Cancer Center research is providing new insights into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.

"Cultures can be very different, nothing is more powerful than family.”

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.

Vanderbilt biochemists got unexpected results when they used their new approach to explore the role of DNA methylation in gene regulation.

James Dewar and colleagues have identified a role for the enzyme topoisomerase II in reducing replication errors during the final stage of DNA synthesis.

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.